Alimera Sciences Inc.

Alimera Sciences Inc.

ALIM

Market Cap$292.33M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Alimera Sciences Inc.Alimera Sciences Inc.00%-5.6-
$5.75

Target Price by Analysts

3.2% upsideAlimera Sciences Target Price DetailsTarget Price
$7.08

Current Fair Value

27% upside

Undervalued by 27% based on the discounted cash flow analysis.

Share Statistics

Market cap$292.33 Million
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Beta0.0
Outstanding Shares52,388,513
Avg 30 Day Volume473,315

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
PEG-0.0
Price to Sales5.57
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income0
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Alimera Sciences Inc.

CEO: Richard Eiswirth